Shitij Kapur, MBBS, PhD
- 12Articles
- 46.2KReads1
- 1999–2016Active
- 43Collaborators
- 609Citations2
About
Shitij Kapur, MBBS, PhD, has authored 12 articles between 1999 and 2016 focusing on schizophrenia and schizoaffective disorders, with a particular emphasis on psychopharmacology. The work includes studies on antipsychotic dosing strategies, receptor occupancy, plasma drug concentrations, and clinical response to medications such as olanzapine, risperidone, quetiapine, and aripiprazole. Kapur's research also explores mechanisms underlying antipsychotic sensitivity and treatment algorithms for first-episode schizophrenia. Frequent collaborators include Gary Remington, Hiroyuki Uchida, and David C. Mamo.
Publications
Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial
October 26, 2016
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
